Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News ESOC 2025

Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke

Todd Neale

May 23, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

L.A. McKeown

November 17, 2023

News Conference News AHA 2023

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Caitlin E. Cox

November 07, 2023

News Daily News

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Michael O'Riordan

July 20, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

News Daily News

E-Cigs in Combination With Cigarettes Don’t Cut Markers of CV Risk

Todd Neale

January 05, 2021

News Conference News AHA 2020

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

L.A. McKeown

November 16, 2020

News Daily News

Higher Inflammatory Food ‘Index’ Linked to CVD Risk

Shelley Wood

November 03, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Michael O'Riordan

April 24, 2019

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

‘Just Move’: Registry Study Shows Positive CV Effects of Light Physical Activity in Older Adults

Yael L. Maxwell

August 08, 2018

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Advertisement

Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

E-Cigs in Combination With Cigarettes Don’t Cut Markers of CV Risk

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

Higher Inflammatory Food ‘Index’ Linked to CVD Risk

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

‘Just Move’: Registry Study Shows Positive CV Effects of Light Physical Activity in Older Adults

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content